Short Interest in SeaStar Medical Holding Co. (NASDAQ:ICUCW) Decreases By 88.8%

SeaStar Medical Holding Co. (NASDAQ:ICUCWGet Free Report) saw a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 14,800 shares, a decline of 88.8% from the January 15th total of 132,100 shares. Based on an average daily trading volume, of 86,200 shares, the short-interest ratio is presently 0.2 days.

Hedge Funds Weigh In On SeaStar Medical

A hedge fund recently bought a new stake in SeaStar Medical stock. Boothbay Fund Management LLC purchased a new position in shares of SeaStar Medical Holding Co. (NASDAQ:ICUCWFree Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 245,200 shares of the company’s stock, valued at approximately $742,000.

SeaStar Medical Trading Up 52.8 %

ICUCW traded up $0.04 during trading on Monday, hitting $0.13. 822,658 shares of the stock were exchanged, compared to its average volume of 114,789. The stock has a fifty day moving average price of $0.05 and a two-hundred day moving average price of $0.04. SeaStar Medical has a 1-year low of $0.01 and a 1-year high of $0.16.

About SeaStar Medical

(Get Free Report)

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.

See Also

Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with's FREE daily email newsletter.